Opaleye Management Inc. 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-11 4:23 pm Sale | 2026-03-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Opaleye Management Inc. | 619,089 2.670% | -949,913 (-60.54%) | Filing |
| 2025-10-17 4:05 pm Purchase | 2025-10-10 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Opaleye Management Inc. | 1,569,002 9.480% | 1,569,002 (New Position) | Filing |